Ultralife Corporation
NASDAQ•ULBI
CEO: Mr. Michael E. Manna
Sector: Industrials
Industry: Electrical Equipment & Parts
Listing Date: 1992-12-23
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables. The Communications Systems segment provides communications systems and accessories to support military communications systems, such as radio frequency amplifiers, power supplies and cables, connector assemblies, amplified speakers, equipment mounts, case equipment, man-portable systems, and integrated communication systems for fixed or vehicle applications comprising vehicle adapters, vehicle installed power enhanced rifleman appliqué systems, and SATCOM systems. This segment's military communications systems and accessories are designed to enhance and extend the operation of communications equipment, such as vehicle-mounted, manpack, and handheld transceivers. The company sells its products under the Ultralife, Ultralife HiRate, Ultralife Thin Cell, Ultralife Batteries, Lithium Power, McDowell Research, AMTITM, ABLETM, ACCUTRONICS, ACCUPRO, ENTELLION, SWE Southwest Electronic Energy Group, SWE SEASAFE, Excell Battery Group, and Criterion Gauge brands through original equipment manufacturers, and industrial and defense supply distributors. In addition, it sells its 9-volt battery to the broader consumer market through national and regional retail chains and online retailers. It serves government, defense, and commercial sectors. The company was incorporated in 1990 and is headquartered in Newark, New York.
Contact Information
Market Cap
$109.02M
P/E (TTM)
-18.5
45
Dividend Yield
--
52W High
$9.52
52W Low
$4.07
52W Range
Rank30Top 19.5%
5.1
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Average • 5.1 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2016-2025
Financial Dashboard
Q4 2025 Data
Revenue
$48.48M+0.00%
4-Quarter Trend
EPS
-$0.45+0.00%
4-Quarter Trend
FCF
$0.00+0.00%
4-Quarter Trend
2025 Q3 Earnings Highlights
Key Highlights
Nine-Month Net Income Decline Nine-month net income $1.52M; diluted EPS $0.09 versus $0.37 reported in prior year period results.
Quarterly Revenue Growth Quarterly revenue grew 21.5% to $43.37M; government/defense sales increased 16.4% reflecting strong demand.
Balance Sheet Equity Growth Total assets reached $222.25M; stockholders' equity increased to $137.43M compared to prior year end.
Debt Reduction Achieved Outstanding Term Loan principal reduced by $4.06M to $50.94M as of September 30, 2025.
Risk Factors
Gross Margin Compression Noted Quarterly gross margin fell 210 basis points to 22.2% due to unfavorable sales mix and quality issues.
Internal Control Material Weakness Material weakness in internal control over financial reporting persists as of September 30, 2025; remediation ongoing.
Operating Cash Flow Decreased Nine-month operating cash flow totaled $9.50M, decreasing from $13.59M generated in the prior year.
Increased Operating Expenses Quarterly operating expenses rose 29.4% to $10.57M, including $1.33M related to the Electrochem acquisition.
Outlook
Rebranding Initiative Impact Comprehensive rebranding consolidating sub-brands under Ultralife will result in non-cash intangible asset adjustments.
Future Liquidity Position Expected positive operating cash flow and Revolving Credit Facility availability sufficient for foreseeable funding needs.
New Accounting Standard Adoption Evaluating impact of ASU 2023-09 regarding income tax disclosures, effective for annual periods beginning 2025.
Capital Expenditure Focus Cash used in investing activities totaled $3.00M, primarily for equipment supporting higher-volume manufacturing transition.
Peer Comparison
Revenue (TTM)
$191.16M
$166.77M
$60.78M
Gross Margin (Latest Quarter)
100.0%
34.7%
34.7%
Key Metrics
Symbol | Market Cap | P/E (TTM) | ROE (TTM) | Debt to Assets |
|---|---|---|---|---|
| GIFI | $191.98M | 21.3 | 9.7% | 12.9% |
| ESP | $171.61M | 16.6 | 19.1% | 0.0% |
| HQI | $153.13M | 21.8 | 10.5% | 2.3% |
Long-Term Trends
Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
-1.5%
Flat Growth
4Q Net Income CAGR
N/M
Profitability Shift
Cash Flow Stability
75%
Volatile Cash Flow
Deep Research
Next earnings:Apr 7, 2026
EPS:-
|Revenue:-
Financials
Earnings Calls
Reports
News
Income Statement
Balance Sheet
Cash Flow Statement
Ratios
% Chg.
Income Statement | LTM |
|---|
No Data